Forecast & Rating8 analysts currently cover DUALITYBIO-B, with about 100.0% giving a positive rating — meaning they expect the stock to rise. The average price target is HK$423.17, about 116.2% upside from the current price of HK$195.70. Price targets span a fair range, indicating some disagreement among institutions. For you, this means most professionals who study DUALITYBIO-B closely still see room for the stock to rise. Data as of Aug 14, 2026; for reference only and not investment advice.
Aug 13, 2026Price forecast
HK$423.17116.24%
Forecast & RatingStrong buy
8analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 24, 2026
Forecast met27.6%
Stock price$195.70
Avg. target$423.2
High target$512
Low target$320
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.